Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ViaDerma, Inc. (OTC: VDRM).

Full DD Report for VDRM

You must become a subscriber to view this report.

Recent News from (OTC: VDRM)

ViaDerma Provides an Update to Shareholders via a Letter from the CEO
LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,   (“Company”)   (OTC Pink:VDRM), is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, . (Link to CEO L...
Source: GlobeNewswire
Date: July, 12 2018 05:00
ViaDerma Announces Increase of Amazon Sales on the Heels of U.S. Department of Commerce Trade Mission to India
LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,   (“Company”)   (OTC Pink:VDRM), is excited to report that since the inaugural sale of VitaStem on Amazon, January 2018, monthly sales continue to increase. In the months of March to April alone, sales i...
Source: GlobeNewswire
Date: May, 29 2018 05:00
United States Commerce Department Invites ViaDerma to Participate in Official Trade Mission to India
LOS ANGELES, May 15, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”)   (OTC Pink:VDRM), is pleased to announce their participation in the upcoming Beauty & Wellness Executive Service Program , hosted by the United States Department of Commerce. ViaDerma P...
Source: GlobeNewswire
Date: May, 15 2018 05:00
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
LOS ANGELES, April 24, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,   (“Company”)   (OTC Pink:VDRM), is pleased to announce it has entered into a $250,000 initial sales agreement with Vage Nigeria Ltd. (“Vage”), a brand support company specializing in produ...
Source: GlobeNewswire
Date: April, 24 2018 05:00
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc.,   (“Company”)   (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem.  ViaDerma launches Wound Care Services Licensing Program. ...
Source: GlobeNewswire
Date: April, 02 2018 08:19
ViaDerma, Inc. Provides an Update of Current Marketing Activities
LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities: ViaDerma is in discussions with a Huntington Beach based international consulting firm, to explore placement of Vitaste...
Source: GlobeNewswire
Date: March, 08 2018 05:00
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled favorably for Kasten.  ViaDerma’s legal counsel, Austin Legal Group was successful i...
Source: GlobeNewswire
Date: March, 02 2018 09:14
U.S. District Court Rules Favorably for Kasten, Inc. on Basis of Legal Allegations Against Defendants Viaderma, Otiko and Phillips
SIOUX FALLS, S.D. , Feb. 26, 2018 /PRNewswire/ -- In mid-2017, Kasten, Inc. (PINK: KAST) joined OPD Holdings, LLC, as a Co-Plaintiff in a South Dakota federal district court lawsuit against several people and entities throughout the United States involving numerous business and i...
Source: PR Newswire
Date: February, 26 2018 13:41
ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court
LOS ANGELES, Feb. 07, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), recently announced the complaint filed by Steven J. Keough in a South Dakota Federal Court, has been dismissed without prejudice. The complaint alleged certain technical issues dating back to 2011. The Company ...
Source: GlobeNewswire
Date: February, 07 2018 05:00
The Lawsuit against ViaDerma, Inc. has been Dismissed in US District Federal Court as the Company Vigorously Defends its Patents, Product Line and its Shareholders
LOS ANGELES, CA --(Marketwired - February 06, 2018) - ViaDerma, Inc. (OTC PINK: VDRM) , a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company's legal counsel, Austin Legal Group, has been successful in having the compla...
Source: Marketwired
Date: February, 06 2018 08:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VDRM.

About ViaDerma, Inc. (OTC: VDRM)

Logo for ViaDerma, Inc. (OTC: VDRM)

ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem cell therapy. The Company s products are normally applied topically using a patent pending delivery system technology created by Dr. Phillips and Dr. Chris Ayo Otiko. Presently, the products are used within the OTC drug market, i.e. non prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies.


Contact Information



Current Management

  • Chris A. Otiko / President, Secretary, Treasurer
  • Chris A. Otiko /

Current Share Structure

  • Market Cap: $5,174,142 - 03/16/2018
  • Authorized: 1,000,000,000 - 03/15/2018
  • Issue and Outstanding: 544,646,475 - 03/15/2018
  • Float: 222,337,825 - 01/25/2017


Recent Filings from (OTC: VDRM)

Filing Type: 1-A POSFiling Source: edgar
Filing Date: May, 03 2018
Filing Type: QUALIFFiling Source: edgar
Filing Date: March, 30 2018
Filing Type: QUALIFFiling Source: edgar
Filing Date: March, 30 2018
Quarterly Report - Disclosure Statement - 11-13-2017
Filing Type: Quarterly Report - Disclosure Statement - 11-13-2017Filing Source: OTC Markets
Filing Date: November, 14 2017
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: November, 13 2017



Daily Technical Chart for (OTC: VDRM)

Daily Technical Chart for (OTC: VDRM)

Stay tuned for daily updates and more on (OTC: VDRM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: VDRM)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VDRM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VDRM and does not buy, sell, or trade any shares of VDRM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: